Bryan T. Mogle

435 total citations
9 papers, 219 citations indexed

About

Bryan T. Mogle is a scholar working on Infectious Diseases, Pharmacology and Clinical Biochemistry. According to data from OpenAlex, Bryan T. Mogle has authored 9 papers receiving a total of 219 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 4 papers in Pharmacology and 4 papers in Clinical Biochemistry. Recurrent topics in Bryan T. Mogle's work include Antimicrobial Resistance in Staphylococcus (5 papers), Bacterial Identification and Susceptibility Testing (4 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). Bryan T. Mogle is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (5 papers), Bacterial Identification and Susceptibility Testing (4 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). Bryan T. Mogle collaborates with scholars based in United States. Bryan T. Mogle's co-authors include Wesley D. Kufel, Jeffrey M. Steele, Robert W. Seabury, Stephen J. Thomas, Utkarsh J. Dang, Christopher D. Miller, Karen Williams, Teresa J. Lubowski and William Darko and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy and International Journal of Antimicrobial Agents.

In The Last Decade

Bryan T. Mogle

8 papers receiving 214 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bryan T. Mogle United States 5 129 75 48 47 42 9 219
Timothy R. Pasquale United States 10 125 1.0× 39 0.5× 57 1.2× 80 1.7× 23 0.5× 16 282
Roopali Sharma United States 7 104 0.8× 66 0.9× 60 1.3× 69 1.5× 23 0.5× 21 367
Laura Labate Italy 9 179 1.4× 21 0.3× 25 0.5× 111 2.4× 38 0.9× 22 304
Amelia N. Deitchman United States 9 66 0.5× 60 0.8× 8 0.2× 44 0.9× 27 0.6× 21 171
Guglielmo Marco Migliorino Italy 10 106 0.8× 15 0.2× 13 0.3× 50 1.1× 56 1.3× 20 201
Mary Banoub United States 8 35 0.3× 30 0.4× 18 0.4× 30 0.6× 20 0.5× 17 147
Margherita Digaetano Italy 9 131 1.0× 12 0.2× 32 0.7× 64 1.4× 99 2.4× 19 253
Jesús Gaytán-Martı́nez Mexico 10 124 1.0× 25 0.3× 66 1.4× 138 2.9× 72 1.7× 33 395
Beatriz Larrú United States 8 93 0.7× 20 0.3× 31 0.6× 43 0.9× 30 0.7× 20 185
Riccardo Ungaro Italy 9 169 1.3× 34 0.5× 14 0.3× 126 2.7× 7 0.2× 19 255

Countries citing papers authored by Bryan T. Mogle

Since Specialization
Citations

This map shows the geographic impact of Bryan T. Mogle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bryan T. Mogle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bryan T. Mogle more than expected).

Fields of papers citing papers by Bryan T. Mogle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bryan T. Mogle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bryan T. Mogle. The network helps show where Bryan T. Mogle may publish in the future.

Co-authorship network of co-authors of Bryan T. Mogle

This figure shows the co-authorship network connecting the top 25 collaborators of Bryan T. Mogle. A scholar is included among the top collaborators of Bryan T. Mogle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bryan T. Mogle. Bryan T. Mogle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Miller, Christopher D., et al.. (2021). A single-center cost analysis assessing a change in vasopressin formulation. American Journal of Health-System Pharmacy. 78(13). 1238–1243. 3 indexed citations
2.
Seabury, Robert W., et al.. (2020). Cost comparison of AUC:MIC– versus trough-based vancomycin monitoring for MRSA bacteremia. Journal of the American Pharmacists Association. 60(5). 729–733. 2 indexed citations
3.
Mogle, Bryan T., et al.. (2019). Ibalizumab, a Novel Monoclonal Antibody for the Management of Multidrug-Resistant HIV-1 Infection. Antimicrobial Agents and Chemotherapy. 63(6). 69 indexed citations
4.
Kufel, Wesley D., et al.. (2019). Providers' knowledge and perceptions regarding antibiotic stewardship and antibiotic prescribing in rural primary care clinics. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 3(3). 601–608. 2 indexed citations
5.
Mogle, Bryan T., Jeffrey M. Steele, Robert W. Seabury, Utkarsh J. Dang, & Wesley D. Kufel. (2018). Implementation of a two-point pharmacokinetic AUC-based vancomycin therapeutic drug monitoring approach in patients with methicillin-resistant Staphylococcus aureus bacteraemia. International Journal of Antimicrobial Agents. 52(6). 805–810. 44 indexed citations
6.
Mogle, Bryan T., et al.. (2018). The Culture of Carbapenem Overconsumption: Where Does It Begin? Results of a Single-Center Survey. Hospital Pharmacy. 54(3). 175–179.
7.
Mogle, Bryan T., et al.. (2018). Association between prothrombin time and bleeding in hospitalized patients receiving rivaroxaban. American Journal of Health-System Pharmacy. 75(22). 1783–1789. 11 indexed citations
8.
Steele, Jeffrey M., et al.. (2017). Unsuccessful treatment of methicillin-resistant Staphylococcus aureus endocarditis with dalbavancin. Journal of Clinical Pharmacy and Therapeutics. 43(1). 101–103. 30 indexed citations
9.
Mogle, Bryan T., et al.. (2017). Clinical review of delafloxacin: a novel anionic fluoroquinolone. Journal of Antimicrobial Chemotherapy. 73(6). 1439–1451. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026